Retatrutide

October 24, 2026 · 3 min read

Retatrutide: what the published phase 2 research shows about a triple-agonist peptide

A research overview of retatrutide, an investigational GIP, GLP-1 and glucagon receptor agonist, and what its published phase 2 trials reported.

Retatrutide · Metabolic research